Catalog
Synthetic ACTH(4–10) analog
Semax
Sister Russian nootropic to Selank — same evidence caveats.
Research-only / unregulatedGrade D — Plausible, unproven
Target
Putative BDNF/NGF modulation
Mechanism of action
Heptapeptide analog of ACTH(4–10) without corticotropic activity. Claimed BDNF/NGF upregulation in rodent models.
Pharmacokinetics
Intranasal.
Clinical context
Russian use in stroke recovery / cognitive complaints. No Western approval.
Safety
Contraindications
- Pregnancy
Adverse effects
- Largely unknown
Covered in modules
Module 13
Cognitive & Nootropic Peptides
Semax, Selank, Cerebrolysin, Dihexa, Cerebrolysin, NSI-189-style claims.
Module 15
Controversies, Pipeline & Frontier
What's in phase II/III right now — and what 2027 will probably look like.
Module 16
Khavinson 'Bioregulator' Peptides — Deep Dive
40+ years of Russian research, one institution, almost no independent replication. What clinicians actually need to know about Epitalon, Pinealon, Vesugen, Vilon, and Cortexin.
Related compounds
Generate prescriber-grade deep dive
Pull in expanded mechanism, PK/PD, dosing strategies for special populations, drug interactions, monitoring cadence, head-to-head differentials, prescriber pearls, and patient FAQs for Semax.
Educational reference. Not medical advice. Always verify against current FDA labeling and local regulatory guidance before prescribing or counseling.